COVID-19 Update: In-person spring programs canceled. Find at-home activities for California or Kansas City, MO

Rosetta Institute of Biomedical Research


An independently funded biomedical research institute dedicated to cancer research and educating tomorrow’s medical professionals.

The Rosetta Institute of Biomedical Research is an independently funded medical research institute founded by Dr. Ryan Holzer, PhD. The institute is funded by internally generated revenue, and by private donations.

We conduct basic and translational research on apoptosis in multiple myeloma and other malignancies, with the ultimate goal of identifying novel driver mutations responsible for tumorigenesis and the emergence of chemoresistant clones. Current research projects include: 1) discovering novel mechanisms of bortezomib (Velcade) resistance in multiple myeloma, 2) characterizing pro-apoptotic signaling pathways activated by Type 1 interferon (IFN-α/β), 3) the identification and characterization of ubiquitin ligases that regulate cell survival, 4) transcriptomic analysis and miRNA profiling of clonal evolution in cancer, 5) the discovery of novel roles for IL-6 family cytokines in hematologic malignancies, 6) The identification of novel alternatively spliced transcripts that contribute to tumor progression and the RNA-binding proteins that regulate rare exon inclusion/exclusion, 7) the role and regulation of autophagy during proteotoxic stress, 8) adaptation to endoplasmic reticulum (ER) stress and mechanisms of ER stress-induced apoptosis, 9) the identification and characterization of the multiple myeloma stem cell compartment and the bortezomib-resistant subclone, 10) The role of hypoxia in drug sensitivity and clonal evolution. A variety of techniques are being used at the Institute to address these questions, including bioinformatic analyses, CRISPR/Cas9 gene editing, tissue culture and mouse models of cancer. In addition, we are engaged in a drug discovery program to identify novel small molecules that combat cancer, neurodegenerative disorders, aging and other diseases related to splicing errors or disturbances in proteostasis.